PAR-19-282: Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/... - 0 views
-
MiamiOH OARS on 23 May 19This Funding Opportunity Announcement (FOA) uses a R61/R33 Phased Innovation Award mechanism to support clinical research applications that are exploratory and developmental in nature and focus on understanding the neurobiological mechanisms underlying Substance Use Disorders (SUD), including fundamental brain function relevant to substance use.